Shared on 21 Oct 25
Fair value Increased 1.28%Narrative Update on Smiths Group Analysts have increased their price target for Smiths Group to £27.00 from £24.70, citing improved profit margin forecasts and a sustained positive outlook, even though revenue growth expectations have moderated. Analyst Commentary Bullish Takeaways Bullish analysts note the upward revision of the price target to 2,700 GBp, reflecting confidence in Smiths Group's ability to drive higher shareholder value.
Shared on 25 Sep 25
Fair value Increased 1.09%Consensus analyst price targets for Smiths Group were little changed despite sharply upgraded revenue growth forecasts (+0.2% to +9.1%), as a substantial decline in net profit margin (12.38% to 10.26%) offset much of the benefit, resulting in only a marginal fair value increase to £24.38. What's in the News Smiths Group is recommending a final dividend of 31.77 pence for the year ended 31 July 2025, bringing the total for the year to 46.0 pence, a year-on-year increase of 5.1%.
Shared on 05 Sep 25
Fair value Increased 0.64%Despite a slight downgrade in revenue growth forecasts and an increase in Smiths Group’s future P/E multiple, the consensus analyst price target has remained effectively unchanged, rising marginally from £23.96 to £24.12. Valuation Changes Summary of Valuation Changes for Smiths Group The Consensus Analyst Price Target remained effectively unchanged, moving only marginally from £23.96 to £24.12.
Shared on 23 Apr 25
Fair value Increased 0.18%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 17 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 09 Apr 25
Fair value Decreased 0.93%AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 02 Apr 25
AnalystConsensusTarget made no meaningful changes to valuation assumptions.
Shared on 26 Mar 25
Fair value Decreased 3.89%AnalystConsensusTarget has decreased revenue growth from 5.3% to 4.7%.
Shared on 12 Mar 25
Fair value Increased 5.40%AnalystConsensusTarget made no meaningful changes to valuation assumptions.

